Neonatal exposure to daidzein, genistein, or the combination modulates bone development in female CD-1 mice

Journal of Nutrition

Volumn 139, Issue 3, 2009, Pages 467-473

  Kaludjerovic, Jovana ^a   Ward, Wendy E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; DIETHYLSTILBESTROL; GENISTEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTIFICIAL MILK; BONE DENSITY; BONE DEVELOPMENT; BONE STRENGTH; COMPRESSION FRACTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMUR; LUMBAR VERTEBRA; MALE; MOUSE; NEWBORN; NONHUMAN; PERINATAL DRUG EXPOSURE; PERINATAL PERIOD; SEX DIFFERENCE; SKELETON; SOYBEAN; TRABECULAR BONE; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DRUG COMBINATION; PHYSIOLOGY; SEXUAL DEVELOPMENT; SPINE;

MUS;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; BONE DENSITY; BONE DEVELOPMENT; DRUG THERAPY, COMBINATION; FEMALE; FEMUR; GENISTEIN; ISOFLAVONES; MALE; MICE; PHYTOESTROGENS; SEX CHARACTERISTICS; SPINE;

EID: 62749123477     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.100115     Document Type: Conference Paper

References (36)

1. U.S. Surgeon General Department of Health and Human Services. Bone health and osteoporosis: a report of surgeon general. Rockville (MD): U.S. Department of Health and Human Services; 2004. p. 1-371.
2. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Looker A, Marcus R, Matkovic V, Weaver C. Peak bone mass. Osteoporos Int. 2000;11: 985-1009.
3. Weaver CM. The growing years and prevention of osteoporosis in later life. Proc Nutr Soc. 2000;59:303-6.
4. Eastell R, Lambert H. Strategies for skeletal health in the elderly. Proc Nutr Soc. 2002;61:173-80.
5. Kelly PJ, Nguyen T, Hopper J, Pocock N, Sambrook P, Eisman JA. Changes in axial bone density with age: a twin study. J Bone Miner Res. 1993;8:11-7.
6. Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Miner Res. 1993;8:1-9.
7. Eisman JA, Kelly PJ, Morrison NA, Pocock NA, Yeoman R, Birmingham J, Sambrook PN. Peak bone mass and osteoporosis prevention. Osteoporos Int. 1993;3 Suppl 1:56-60.
8. Lloyd T, Taylor DS. Calcium intake and peak bone mass. J Am Med Womens Assoc. 2001;56:49-52.
9. Mølgaard C, Lykke TB, Fleischer MK. The influence of calcium intake and physical activity on bone mineral content and bone size in healthy children and adolescents. Osteoporos Int. 2001;12:887-94.
10. Stallings VA. Calcium and bone health in children: a review. Am J Ther. 1997;4:259-73.
11. Reinwald S, Weaver CM. Soy isoflavones and bone health: a doubleedged sword? J Nat Prod. 2006;69:450-9.
12. Silbergeld EK, Flaws JA, Brown KM. Organizational and activational effects of estrogenic endocrine disrupting chemicals. Cad Saude Publica. 2002;18:495-504.
13. Migliaccio S, Newbold RR, McLachlan JA, Korach KS. Alterations in estrogen levels during development affects the skeleton: use of an animal model. Environ Health Perspect. 1995;103 Suppl 7:95-7.
14. Migliaccio S, Newbold RR, Teti A, Jefferson WJ, Toverud SU, Taranta A, Bullock BC, Suggs CA, Spera G, et al. Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood. Bone. 2000;27:47-52.
15. Piekarz AV, Ward WE. Effect of neonatal exposure to genistein on bone metabolism in mice at adulthood. Pediatr Res. 2007;61:48-53.
16. Delclos KB, Bucci TJ, Lomax LG, Latendresse JR, Warbritton A, Weis CC, Newbold RR. Effects of dietary genistein exposure during development on male and female CD (SpragueDawley) rats. Reprod Toxicol. 2001;15:647-63.
17. Health Canada. Alternate milks: infant formulas. 2005 [cited 2008 Apr 24]. Available from: http://www.hc-sc.gc.ca/fn-an/pubs/infantnourrisson/nut- infant-nourrisson-term-4-e.html.
18. Sheehan D, Watt S, Krueger P, Sword W The impact of a new universal postpartum program on breastfeeding outcomes. J Hum Lact. 2006; 22:398-408.
19. Canadian Community Health Survey. Breastfeeding practices, females age 15-55 who had a baby in the previous 5 years, Canada, provinces, territories and peer groups. Ottawa: Statistics Canada; 2003.
20. CDC. Breastfeeding trends and updated national health objectives for exclusive breastfeeding: United States, birth years 2000-2004. MMWR Morb Mortal Wkly Rep. 2007;56:760-3.
21. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr. 1998;68:S1453-61.
22. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phytooestrogens from soy-based infant formula. Lancet. 1997; 350:23-7.
23. Greendale GA, FitzGerald G, Huang M-H, Sternfeld B, Gold E, Seeman T, Sherman S, Sowers M. Dietary soy isoflavones and bone mineral density: results from the study of women's health across the nation. Am J Epidemiol. 2002;155:746-54.
24. Kimira M, Arai Y, Shimoi K, Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 1998;8:168-75.
25. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A Diet. J Nutr. 1997;127:S838-41.
26. Barnes S, Coward L, Kirk M, Sfakianos J. HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med. 1998;217:254-62.
27. Ward WE, Piekarz AV, Fonseca D. Bone mass, bone strength, and their relationship in developing CD-I mice. Can J Physiol Pharmacol. 2007; 85:274-9.
28. Canadian Council on Animal Care. Guide to the care and use of experimental animals. Ottawa: Canada Council on Animal Care; 1993. p. 1-212.
29. Fonseca D, Ward WE. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone. 2004;35:489-97.
30. Jefferson WN, Couse JF, Banks EP, Korach KS, Newbold RR. Expression of estrogen receptor {beta} is developmentally regulated in reproductive tissues of male and female mice. Biol Reprod. 2000; 62:310-7.
31. Recker RR, Barger-Lux MJ. Transilian bone biopsy. In: Bilezikian J, Raisz L, Rodan G, editors. Principles of bone biology. 2nd ed. London: Academic Press; 2002. p. 1625-34.
32. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor {beta}. Endocri nology. 1998;139:4252-63.
33. Benhamou CL. Effects of osteoporosis medications on bone quality. Joint Bone Spine. 2006;74:39-47.
34. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20:63-8.
35. Penolazzi L, Lambertini E, Giordano S, Sollazzo V, Traina G, del Senno L, Piva R. Methylation analysis of the promoter F of estrogen receptor [alpha] gene: effects on the level of transcription on human osteoblastic cells. J Steroid Biochem Mol Biol. 2004;91:1-9.
36. Nilsson O, Mitchum RD Jr, Schrier L, Ferns SP, Barnes KM, Troendle JF, Baron J. Growth plate senescence is associated with loss of DNA methylation. J Endocrinol. 2005;186:241-9.